Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians.

CONCLUSIONS: The outcome of treatment of OUD with medications is likely a complex function of multiple factors, including environmental, psychosocial, and possibly genetic, such that major effects of genetic variants may be unlikely. PMID: 32851876 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32851876?dopt=Abstract

Source: The American Journal of Drug and Alcohol Abuse - August 26, 2020 Category: Addiction Authors: Randesi M, Rotrosen J, Nunes EV, Lee JD, Novo P, Levran O, Ott J, Pavlicova M, Scodes J, Kreek MJ Tags: Am J Drug Alcohol Abuse Source Type: research